Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells
Nathalie Scamuffa, … , Nabil G. Seidah, Abdel-Majid Khatib
Nathalie Scamuffa, … , Nabil G. Seidah, Abdel-Majid Khatib
Published December 6, 2007
Citation Information: J Clin Invest. 2008;118(1):352-363. https://doi.org/10.1172/JCI32040.
View: Text | PDF
Research Article Oncology

Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells

  • Text
  • PDF
Abstract

The proprotein convertases (PCs) are implicated in the activation of various precursor proteins that play an important role in tumor cell metastasis. Here, we report their involvement in the regulation of the metastatic potential of colorectal tumor cells. PC function in the human and murine colon carcinoma cell lines HT-29 and CT-26, respectively, was inhibited using siRNA targeting the PCs furin, PACE4, PC5, and PC7 or by overexpression of the general PC inhibitor α1-antitrypsin Portland (α1-PDX). We found that overexpression of α1-PDX and knockdown of furin expression inhibited processing of IGF-1 receptor and its subsequent activation by IGF-1 to induce IRS-1 and Akt phosphorylation, all important in colon carcinoma metastasis. These data suggest that the PC furin is a major IGF-1 receptor convertase. Expression of α1-PDX reduced the production of TNF-α and IL-1α by human colon carcinoma cells, and incubation of murine liver endothelial cells with conditioned media derived from these cells failed to induce tumor cell adhesion to activated murine endothelial cells, a critical step in metastatic invasion. Furthermore, colon carcinoma cells in which PC activity was inhibited by overexpression of α1-PDX when injected into the portal vein of mice showed a significantly reduced ability to form liver metastases. This suggests that inhibition of PCs is a potentially promising strategy for the prevention of colorectal liver metastasis.

Authors

Nathalie Scamuffa, Geraldine Siegfried, Yannick Bontemps, Liming Ma, Ajoy Basak, Ghislaine Cherel, Fabien Calvo, Nabil G. Seidah, Abdel-Majid Khatib

×

Figure 1

Inhibition of PC activity in HT-29 and CT-26 colon cancer cells.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of PC activity in HT-29 and CT-26 colon cancer cells.
(A) RT-...
(A) RT-PCR analysis was performed on RNA extracted from the colon cancer cells HT-29 and CT-26 and the same cells that express the PC inhibitor α1-PDX (HT-29/PDX and CT-26/PDX) using furin, PACE4, PC5, PC7, and GAPDH-specific primers. All these PCs were present in HT-26 and HT-29/PDX cells, whereas CT-26 and CT-26/PDX cells lacked the expression of PC5 and PACE4. (B–E) PDGF-A and IGF-1R processing was analyzed in the indicated cells by Western blotting using an anti-V5 (B and C) and anti–IGF-1R antibody (D and E), respectively. Note that α1-PDX inhibited the processing of these PC substrates, and only furin mediated complete rescue. Bars denote the corresponding percentages of pro-PDGF-A and pro-IGF-1R accumulation. Values are mean ± SEM (n = 3 per group). *P < 0.005; **P < 0.0002.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts